Plasmids encoding granulocyte-macrophage colony-stimulating factor and CD154 enhance the immune response to genetic vaccines

Vaccine

Volumn 19, Issue 15-16, 2001, Pages 2181-2189

  Burger, Jan A ^a   Mendoza, Robert B ^a   Kipps, Thomas J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cytotoxic T lymphocytes; Immunomodulators; Th1 Th2; Vaccination

Indexed keywords

BETA GALACTOSIDASE; DNA VACCINE; GLYCOPROTEIN GP 39; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN G ANTIBODY; IMMUNOLOGICAL ADJUVANT; PLASMID DNA; TUMOR ANTIGEN; TUMOR VACCINE; VIRUS ANTIGEN; VIRUS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN PRESENTING CELL; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; HELA CELL; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOSTIMULATION; MASTOCYTOMA; MOUSE; NONHUMAN; PLASMID; PRIORITY JOURNAL; SPLEEN CELL; VACCINATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; BETA-GALACTOSIDASE; CD40 LIGAND; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; IMMUNOGLOBULIN G; LAC OPERON; MICE; MICE, INBRED BALB C; PLASMIDS; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED; VACCINES, DNA;

EID: 0035961503     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(00)00382-0     Document Type: Article

References (46)

1. Gene vaccination with naked plasmid DNA: Mechanism of CTL priming
2. DNA vaccination: Transfection and activation of dendritic cells as key events for immunity
3. DNA-based immunization by in vivo transfection of dendritic cells
4. Gene vaccination: Plasmid DNA is more than just a blueprint
5. Emerging applications of recombinant human granulocyte-macrophage colony-stimulating factor
6. Granulocyte/macrophage colony-stimulating factor and interleukin 1 mediate the maturation of murine epidermal Langerhans cells into potent immunostimulatory dendritic cells
7. GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells
8. Novel responses of human skin to intradermal recombinant granulocyte/macrophage-colony-stimulating factor: Langerhans cell recruitment, keratinocyte growth, and enhanced wound healing
9. Granulocyte-macrophage colony-stimulating factor: An effective adjuvant for protein and peptide-based vaccines
10. Different cytokines regulate antigen uptake and presentation of a precursor dendritic cell line
11. Generation of tumor immunity by bone marrow-derived dendritic cells correlates with dendritic cell maturation stage
12. Dendritic cells require maturation via CD40 to generate protective antitumor immunity
13. Activation of human dendritic cells through CD40 cross-linking
14. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation
15. Help for cytotoxic-T-cell responses is mediated by CD40 signalling
16. A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell
17. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions
18. CD40 activation in vivo overcomes peptide-induced peripheral cytotoxic T-lymphocyte tolerance and augments anti-tumor vaccine efficacy
19. Conversion of tumor-specific CD4+ T-cell tolerance to T-cell priming through in vivo ligation of CD40
20. Immunostimulatory effects of a plasmid expressing CD40-ligand (CD154) on gene immunization
21. Class I-restricted processing and presentation of exogenous cell-associated antigen in vivo
22. Deoxyribonucleic acid vaccines encoding antigens with rapid proteasome-dependent degradation are highly efficient inducers of cytolytic T lymphocytes
23. Reduction in mitochondrial membrane potential is an early event in fas-independent CTL-mediated apoptosis
24. Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells
25. Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines
26. Protective immunity against heterologous challenge with encephalomyocarditis virus by VP1 DNA vaccination: Effect of coinjection with a granulocyte-macrophage colony stimulating factor gene
27. Enhancement of cellular and humoral immune responses to hepatitis C virus core protein using DNA-based vaccines augmented with cytokine-expressing plasmids
28. Enhancement of protective humoral (Th2) and cell-mediated (Th1) immune responses against herpes simplex virus-2 through co-delivery of granulocyte-macrophage colony-stimulating factor expression cassettes
29. Immunological memory after somatic transgene immunization is positively affected by priming with GM-CSF and does not require bone marrow-derived dendritic cells
30. Intranasal immunization of a DNA vaccine with IL-12- and granulocyte-macrophage colony-stimulating factor (GM-CSF)-expressing plasmids in liposomes induces strong mucosal and cell-mediated immune responses against HIV-1 antigens
31. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity
32. Irradiated tumor cells adenovirally engineered to secrete granulocyte/macrophage-colony-stimulating factor establish antitumor immunity and eliminate pre-existing tumors in syngeneic mice
33. Rapid adenoviral transduction of freshly resected tumour explants with therapeutically useful genes provides a rationale for genetic immunotherapy for colorectal cancer
34. Genetic immunotherapy of established tumors with adenovirus-murine granulocyte-macrophage colony-stimulating factor
35. Gene immunotherapy in murine acute myeloid leukemia: Granulocyte-macrophage colony-stimulating factor tumor cell vaccines elicit more potent antitumor immunity compared with B7 family and other cytokine vaccines
36. Phase I study of non-replicating autologous tumor cell injections using cells prepared with or without GM-CSF gene transduction in patients with metastatic renal cell carcinoma
37. A case report: Immune responses and clinical course of the first human use of granulocyte/macrophage-colony-stimulating-factor-transduced autologous melanoma cells for immunotherapy
38. Immunization with recombinant human granulocyte-macrophage colony-stimulating factor as a vaccine adjuvant elicits both a cellular and humoral response to recombinant human granulocyte-macrophage colony-stimulating factor
39. Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte-macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma
40. Development of Th1 and Th2 populations and the nature of immune responses to hepatitis B virus DNA vaccines can be modulated by codelivery of various cytokine genes
41. Immunostimulatory CpG oligodeoxynucleotides enhance the immune response to vaccine strategies involving granulocyte-macrophage colony-stimulating factor
42. Delivery of multiple CD8 cytotoxic T cell epitopes by DNA vaccination
43. Lymphokine control of in vivo immunoglobulin isotype selection
44. Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants
45. Oligonucleotide adjuvants for T helper 1 (Th1)-specific vaccination
46. CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity